Hyperuricemia Therapeutic Market is driven by increasing gout...

a adăugat un sunet Health

2025-06-17 10:06:18 -

Hyperuricemia Therapeutic Market is driven by increasing gout prevalence

The Hyperuricemia Therapeutic Market encompasses a range of prescription drugs and biologics designed to reduce elevated uric acid levels and prevent gout flares, kidney stones, and related comorbidities. Key product categories include xanthine oxidase inhibitors, urate transporter inhibitors, and recombinant uricase enzymes. These therapies offer advantages such as targeted action, improved...

0 Commentarii 0 Distribuiri 103 Views 0 previzualizare